Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oxy-PICU Neurodevelopmental Follow-up Study

NCT06734715 is registered in ClinicalTrials.gov with Intensive Care National Audit & Research Centre as lead sponsor.

NCT NCT06734715
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06734715 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oxy-PICU Neurodevelopmental Follow-up Study
Lead sponsor
Intensive Care National Audit & Research Centre
Phase
Observational
Overall status
Not yet recruiting
Start date
January 31, 2025
Completion date
September 30, 2026
Enrollment
556 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

intensive care pediatric